Skip to product information
1 of 1

VisioCyt® Bladder

VisioCyt® Bladder

VisioCyt® Bladder allows an earlier diagnosis and monitoring of bladder cancer from a simple urine sample.

This innovative solution is based on a patented technology combining image analysis and artificial intelligence.

VisioCyt® Bladder, validated by a clinical multicentric prospective trial, is CE IVDR marked.

More information about VisioCyt®

Keywords

  • Innovative Solution
  • Earlier Cancer Diagnosis
  • AI Technology
  • High-Tech Imaging
  • CE Marked

About

VITADX

VitaDX, a deep tech based in Rennes and Paris, develops and markets cancer diagnostic solutions combining artificial intelligence and image processing applied to cytology.

View full details

Discover more about VITADX